Treatment-Resistant Depression
Registration |
---|
You must log in or create an account before enrolling in this educational activity. Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage. |
Target Audience
Healthcare professionals.
Objectives
- Define Treatment-Resistant Depression (TRD).
- Identify multiple non-pharmacological treatment options for TRD.
- Identify multiple pharmacological treatment options for TRD.
Speakers
Douglas Steenblock, MD
Chief of Mental Health Services, Iowa Veterans Home
Sean Barrett, DO
Second Year Resident, Broadlawns UnityPoint Psychiatry Residency Program
Terms of Use and Privacy Policy
Recording date: November 4, 2022
Date of original release: November 27, 2022
Most recent review/update: November 27, 2022
Termination date: November 26, 2025
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Educational Grants
No ineligible company provided financial support for this continuing education activity.
DISCLOSURE
The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.
- Sean Barrett, DO - Speaker. Dr. Barrett has no financial relationships to disclose but does intend to discuss the off-label use of a commercial product.
- Douglas F. Steenblock, MD - Planning Committee Member, Moderator, and Speaker. Dr. Steenblock has no financial relationships to disclose but does intend to discuss the off-label use of a commercial product.
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
- 1.00 IBON